The second study included 38 female patients with BPD, 11 of which were using serotonin reuptake inhibitor (SRI) to treat nervous bulimia or depression, and found increased levels of TNF-α and IL-6 (50) compared to 22 healthy women. Here, IL6 is linked to depressive disorder.